Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study Pharmaceutical Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo plus Yervoy with Two Cycles of Chemotherapy for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer Biotech Investing
Pfizer Announces Positive Phase 3 Study Results for XELJANZ ® in Ankylosing Spondylitis Pharmaceutical Investing
XTANDI® Approved by China NMPA for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer Pharmaceutical Investing
AbbVie to Highlight Blood Cancer Leadership and Advancing Oncology Pipeline at the ASH 62ND Annual Meeting Biotech Investing
Gilead and Kite to Share Latest Scientific Advances in Hematologic Malignancies at ASH 2020 Biotech Investing
Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock Pharmaceutical Investing
Bristol Myers Squibb Data at ACR Convergence 2020 Underscore Commitment to Advancing Science for Patients with Difficult-to-Treat Immune-Mediated Diseases Biotech Investing
